Broccoli sprout extract to reduce tobacco cancer-causing chemicals
Part of Cancer clinical trials.
This Phase 2 study tests whether broccoli sprout extract (Avmacol ES) can reduce cancer-causing substances linked to heavy smoking. It’s for adults who smoke heavily and may help lower harmful tobacco-related chemical effects in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You currently smoke tobacco at least 10 cigarettes per day, with 20 or more pack-years of smoking history
- You’re age 18 or older
- Your body seems strong enough for the study (Karnofsky score 70% or higher)
- Your blood counts and liver/kidney labs are within required limits (including neutrophils, platelets, bilirubin, AST/ALT, and creatinine)
- You can use effective birth control if you could become pregnant (or your partner could), and you will avoid pregnancy during the study
- You can sign written consent and understand what the study involves
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a quit program that combines counseling with medicines (nicotine replacement, varenicline, or bupropion) helps people stop or cut down smoking. It’s also delivered through telehealth, with repeated check-ins to see how well the plan works and whether it’s safe for you.
This study tests how changing the amount of nicotine in e-cigarettes affects people's behavior. It looks at two groups: young adults who already vape and older adult smokers who want to try vaping, to see if different nicotine levels can help reduce smoking or make vaping safer.
This trial tests if eating broccoli microgreens can improve metabolism in obese breast cancer survivors. Participants will avoid other cruciferous vegetables during the study to see how the microgreens affect their health.
This trial studies how a natural compound from broccoli sprouts (sulforaphane) and exercise, alone or together, affect your body's immune and metabolic health. It's for healthy, active adults aged 19–35.
This trial tests nicotine pouches (like small pouches you put in your mouth) as a way to help people who smoke cigarettes or use moist snuff. It studies how your body reacts to these pouches under controlled conditions and during daily life.
This trial tests whether the SurVaxM vaccine can help prevent lung cancer in people who are at high risk because of their smoking history. It is designed for current or former smokers with a significant smoking history.
Hear when a new Cigarette Smoking-Related Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.